Zobrazeno 1 - 10
of 72
pro vyhledávání: '"A K Eremkina"'
Publikováno v:
Терапевтический архив, Vol 90, Iss 10, Pp 115-127 (2018)
A high prevalence of vitamin D deficiency and its negative consequences for health is identified as area of primary concern for scientists and clinicians worldwide. Vitamin D deficiency affects not only bone health but many socially significant acute
Externí odkaz:
https://doaj.org/article/a619f669953440ce93dc1f954e3f2f58
Publikováno v:
Терапевтический архив, Vol 89, Iss 10, Pp 80-86 (2017)
Hypoparathyroidism is an endocrine disease that results from deficiency or complete absence of parathyroid hormone (PTH), a biologically active 84-amino acid polypeptide. Standard therapy for chronic hypoparathyroidism includes oral calcium salts and
Externí odkaz:
https://doaj.org/article/98a81193d2474ca4843c1bf230156d31
Autor:
A. S. Bondarenko, E. E. Bibik, V. V. Voskoboynikov, O. I. Kolegaeva, A. I. Sazonova, A. K. Eremkina, O. V. Lunyakina, T. Yu. Ionanidze, A. A. Aksenenko, R. M. Esayan, N. K. Tetruashvili, N. M. Platonova, N. G. Mokrysheva
Publikováno v:
Акушерство, гинекология и репродукция, Vol 18, Iss 3, Pp 414-424 (2024)
Primary hyperparathyroidism (PHPT) in pregnant women is a rare condition, often remaining undiagnosed due to non-specific clinical symptoms. However, it can lead to life-threatening complications for both the mother and fetus. In vitro fertilization
Externí odkaz:
https://doaj.org/article/9efb6e6a12de46c6b02b4ae53719120e
Publikováno v:
Ожирение и метаболизм, Vol 20, Iss 4, Pp 309-317 (2024)
BACKGROUND: Chronic hypoparathyroidism is a relatively rare disease, which usually treated active forms of vitamin D and oral calcium supplements. Supplementation with native vitamin D can be useful both for achieving «non-skeletal» effects of vita
Externí odkaz:
https://doaj.org/article/474358d4e23c4a5eaa3670f6be62aef1
Autor:
A. M. Gorbacheva, E. E. Bibik, E. A. Dobreva, A. R. Elfimova, A. K. Eremkina, N. G. Mokrysheva
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 4, Pp 358-368 (2023)
BACKGROUND: Primary hyperparathyroidism (PHPT), one of the most common endocrine pathologies, is associated with a higher incidence of cardiovascular diseases, in particular, those caused by endothelial dysfunction. Evaluation of endothelial dysfunct
Externí odkaz:
https://doaj.org/article/c8af419d5d68488daf7b189f7ad40c5a
Autor:
Ekaterina E. Bibik, Ekaterina A. Dobreva, Alina R. Elfimova, Anastasiia P. Miliutina, Anna K. Eremkina, Anna M. Gorbacheva, Julia A. Krupinova, Ekaterina O. Koksharova, Igor A. Sklyanik, Alexander Y. Mayorov, Natalia G. Mokrysheva
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Components of metabolic syndrome can be observed in patients with primary hyperparathyroidism (PHPT). The link between these disorders remains unclear due to the lack of relevant experimental models and the heterogeneity of examin
Externí odkaz:
https://doaj.org/article/718e3c16d3414e56883385f55b3c1378
Autor:
Ekaterina A. Dobreva, Anna M. Gorbacheva, Ekaterina E. Bibik, Anna K. Eremkina, Alina R. Elfimova, Rustam Kh. Salimkhanov, Elena V. Kovaleva, Irina S. Maganeva, Natalia G. Mokrysheva
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionCardiovascular diseases (CVD) and metabolic disorders (MD) have retained leading positions in the structure of morbidity and mortality for many years. Primary hyperparathyroidism (PHPT) is also associated with a greater incidence of CVD a
Externí odkaz:
https://doaj.org/article/9189aeccdd9049e3864549a5557697c5
Changes of metabolic parameters in patients with primary hyperparathyroidism of different age groups
Autor:
E. E. Bibik, A. M. Gorbacheva, E. A. Dobreva, A. R. Elfimova, A. K. Eremkina, N. G. Mokrysheva
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 3, Pp 242-251 (2023)
BACKGROUND: Studies have shown a high incidence of metabolic disorders and cardiovascular diseases in patients with primary hyperparathyroidism (PHPT). PHPT is usually diagnosed in people of age over 50 years and therefore age-associated changes of m
Externí odkaz:
https://doaj.org/article/1df770c796d44d15b3d38c7ddc884776
Autor:
I. S. Maganeva, A. K. Eremkina, A. P. Miliutina, S. A. Martynov, A. S. Severina, R. H. Salimkhanov, M. I. Evloeva, M. Sh. Shamkhalova, M. V. Shestakova, N. G. Mokrysheva
Publikováno v:
Сахарный диабет, Vol 25, Iss 6, Pp 512-522 (2023)
BACKGROUND: In patients with end-stage CKD, receiving renal replacement therapy (RRT) with programmed hemodialysis (HD), the severity of complications is associated with metabolic disturbances: accumulation of uremic toxins, nephrogenic anemia, secon
Externí odkaz:
https://doaj.org/article/ab043f3f660e4dc087ac88de9c66acc9
Autor:
Natalia G. Mokrysheva, Anna K. Eremkina, Alina R. Elfimova, Elena V. Kovaleva, Anastasiia P. Miliutina, Ekaterina E. Bibik, Anna M. Gorbacheva, Ekaterina A. Dobreva, Irina S. Maganeva, Julia A. Krupinova, Rustam H. Salimkhanov, Lizaveta A. Aboishava, Elena V. Karaseva, Galina A. Melnichenko, Ivan I. Dedov
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionUntil recently no major epidemiological research of primary hyperparathyroidism (PHPT) has been conducted in the Russian Federation, this led to the creation of the Russian online registry. The objective of this study is to estimate the c
Externí odkaz:
https://doaj.org/article/940ec9693c5c4e83aa1d86a6523526fe